Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium -
Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.
Minerva Anestesiol. 2021 Nov;87(11):1217-1225. doi: 10.23736/S0375-9393.21.15711-6. Epub 2021 Aug 2.
Fever has been reported as a common symptom in COVID-19 patients. The aim of the study was to describe the characteristics of COVID-19 critically ill patients with fever and to assess if fever management had an impact on some physiologic variables.
This is a retrospective monocentric cohort analysis of critically ill COVID-19 patients admitted to the Department of Intensive Care Unit (ICU) of Erasme Hospital, Brussels, Belgium, between March 2020 and May 2020. Fever was defined as body temperature ≥38 °C during the ICU stay. We assessed the independent predictors of fever during ICU stay. We reported the clinical and physiological variables before and after the first treated episode of fever during the ICU stay.
A total of 72 critically ill COVID-19 patients were admitted to the ICU over the study period and were all eligible for the final analysis; 53 (74%) of them developed fever, after a median of 4 [0-13] hours since ICU admission. In the multivariable analysis, male gender (OR 5.41 [C.I. 95% 1.34-21.92]; P=0.02) and low PaO
In our study, male gender and severe impairment of oxygenation were independently associated with fever in critically ill COVID-19 patients. Fever treatment reduced heart rate and respiratory rate and improved systemic oxygenation.
发热是 COVID-19 患者的常见症状。本研究旨在描述 COVID-19 危重症患者发热的特征,并评估发热管理是否对某些生理变量有影响。
这是一项回顾性单中心队列分析,纳入了 2020 年 3 月至 5 月期间比利时布鲁塞尔 Erasme 医院重症监护病房(ICU)收治的危重症 COVID-19 患者。发热定义为 ICU 住院期间体温≥38°C。我们评估了 ICU 住院期间发热的独立预测因素。报告了 ICU 住院期间首次治疗发热前后的临床和生理变量。
研究期间共有 72 例危重症 COVID-19 患者入住 ICU,均符合最终分析标准;其中 53 例(74%)在入住 ICU 后 4 [0-13] 小时内出现发热。多变量分析显示,男性(OR 5.41 [95%CI 1.34-21.92];P=0.02)和低 PaO
在本研究中,男性和严重的氧合功能障碍与危重症 COVID-19 患者发热独立相关。发热治疗降低了心率和呼吸频率,改善了全身氧合。